Distribution of albumin nanoparticles in animals induced with the experimental allergic encephalomyelitis

scientific article published in January 2000

Distribution of albumin nanoparticles in animals induced with the experimental allergic encephalomyelitis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3109/10611860008997907
P698PubMed publication ID11328657

P2093author name stringVillarroya H
Irache JM
Merodio M
Mirshahi M
Eclancher F
P2860cites workSuppression of experimental allergic encephalomyelitis by the encephalitogenic peptide, in solution or bound to liposomesQ43459944
Body distribution of fully biodegradable [14C]-poly(lactic acid) nanoparticles coated with albumin after parenteral administration to ratsQ45803643
Treatment of spinal cord-induced experimental allergic encephalomyelitis in the Lewis rat with liposomes presenting central nervous system antigensQ46372263
Suppression of experimental allergic encephalomyelitis (EAE) with liposome-encapsulated protease inhibitor: therapy through the blood-brain barrierQ46918469
Early detection of liposome brain localization in rat experimental allergic encephalomyelitisQ48220773
Myelin protein expression in lymphoid tissues: implications for peripheral toleranceQ48363174
Improving drug delivery to intracerebral tumor and surrounding brain in a rodent model: a comparison of osmotic versus bradykinin modification of the blood-brain and/or blood-tumor barriersQ48379162
Suppression of chronic-relapsing experimental allergic encephalomyelitis in strain-13 guinea pigs by administration of liposome-associated myelin basic proteinQ48608889
Inhibition of blood-brain barrier disruption in experimental allergic encephalomyelitis by short-term therapy with dexamethasone or cyclosporin A.Q52507201
The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitisQ53438445
The role of magnetic resonance techniques in understanding and managing multiple sclerosisQ32067232
Herpesviruses--a rationale for antiviral treatment in multiple sclerosisQ33631998
Determinants of passive drug entry into the central nervous systemQ33851314
Peripheral injections of Freund's adjuvant in mice provoke leakage of serum proteins through the blood-brain barrier without inducing reactive gliosisQ33865528
Blood-brain barrier permeability to small and large moleculesQ33904234
Recent advances in the brain targeting of neuropharmaceuticals by chemical delivery systemsQ33904251
Changes in the normal appearing brain tissue and cognitive impairment in multiple sclerosisQ35455319
Adeno-associated viral-mediated catalase expression suppresses optic neuritis in experimental allergic encephalomyelitisQ36802175
Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in ratsQ38548001
Macrophages in T cell line-mediated, demyelinating, and chronic relapsing experimental autoimmune encephalomyelitis in Lewis ratsQ41348774
Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophagesQ42017099
P433issue5
P921main subjectnanoparticleQ61231
P304page(s)289-303
P577publication date2000-01-01
P1433published inJournal of Drug TargetingQ6295099
P1476titleDistribution of albumin nanoparticles in animals induced with the experimental allergic encephalomyelitis
P478volume8

Reverse relations

cites work (P2860)
Q37561363Alterations in blood-brain barrier ICAM-1 expression and brain microglial activation after lambda-carrageenan-induced inflammatory pain
Q38896543Application of nanomedicine for crossing the blood-brain barrier: Theranostic opportunities in multiple sclerosis.
Q35082117Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Q39017307Biopolymeric nanoparticles
Q33682239Centrally Administered Pertussis Toxin Inhibits Microglia Migration to the Spinal Cord and Prevents Dissemination of Disease in an EAE Mouse Model
Q36690735Cessation of blood-to-brain influx of interleukin-15 during development of EAE
Q37890639Nanomedicine: novel approaches in human and veterinary therapeutics
Q44325852Therapeutic effect of transplanted human Wharton's jelly stem cell-derived oligodendrocyte progenitor cells (hWJ-MSC-derived OPCs) in an animal model of multiple sclerosis.

Search more.